Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

Add CLDX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/2/2018 11:01:07 AM - Followers: 96 - Board type: Free - Posts Today: 0



 Celldex Therapeutics, Inc. (CLDX)





Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline:
News and Press Releases:


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes
Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

yes November 8, 2016  yes

From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 







All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Statement of Changes in Beneficial Ownership (4) 01/03/2018 07:00:14 AM
CLDX News: Current Report Filing (8-k) 12/29/2017 07:31:35 AM
CLDX News: Amended Statement of Ownership (sc 13g/a) 12/11/2017 10:39:58 AM
CLDX News: Statement of Changes in Beneficial Ownership (4) 12/01/2017 08:28:02 AM
CLDX News: Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors 11/30/2017 08:01:00 AM
#1505   Nice pop today! erehdogmai 01/02/18 11:01:07 AM
#1504   The problem with that logic is trying to trebeg 12/23/17 11:54:25 PM
#1503   I’ll reload again when the tax loss sales erehdogmai 12/22/17 02:26:20 PM
#1502   Buy buy buy, oppertunity is now people, this harry crumb 12/22/17 02:13:17 PM
#1501   Nice and GLTU! CLDX$$$$ trebeg 12/20/17 07:56:46 PM
#1500   We're on the same page Harry. CLDX$$$$ trebeg 12/20/17 07:46:36 PM
#1499   I’m back in. Added more to my core erehdogmai 12/20/17 03:44:43 PM
#1498   Patience! harry crumb 12/20/17 03:07:43 PM
#1497   The pipeline became much deeper when they acquired trebeg 12/15/17 01:29:37 AM
#1496   Why? What lead to that massive drop in 2014shelby 12/14/17 08:41:21 PM
#1495   Getting Glemba approved through the next phase will trebeg 12/13/17 11:57:40 PM
#1494   Shorts are controlling it but have allowed the harry crumb 12/12/17 10:33:17 AM
#1493   Hopefully the pattern of the PPS dropping back trebeg 12/04/17 01:18:38 AM
#1492   what is with the $3 cap on this stock? noretreat 11/30/17 03:26:06 PM
#1491   Not for long as catalysts are near an harry crumb 11/29/17 07:42:54 PM
#1490   PPS looks very controlled 2014shelby 11/29/17 06:28:08 PM
#1489   Nice trend recently although on somewhat light volume trebeg 11/17/17 12:28:14 AM
#1488   Well gl to ya harry crumb 11/13/17 10:34:32 PM
#1487   Ok. Been down for a looooong time 2014shelby 11/09/17 10:24:02 PM
#1486   You may very well be right Harry but letsgogolfing 11/09/17 08:23:55 PM
#1485   been adding an accumulating, not selling/flipping anything. like harry crumb 11/07/17 10:04:21 PM
#1484   Yup same here. Well played. erehdogmai 11/07/17 01:19:05 PM
#1483   Couldn't resist had to take some profits on trebeg 11/07/17 01:16:01 PM
#1482   Nice little pop. Enjoy! erehdogmai 11/07/17 10:35:55 AM
#1481   Yeah, we may bounce around a bit but trebeg 11/02/17 10:55:02 PM
#1480   Got me a little concerned today but it erehdogmai 11/02/17 11:47:12 AM
#1479   Beer money good! LOL Not so sure this trebeg 11/01/17 08:02:30 AM
#1478   Bought Friday, already sold. It had a nice erehdogmai 10/31/17 11:16:07 PM
#1477   Bet you thought the PPS was going up trebeg 10/31/17 10:25:52 PM
#1476   Back in @2.36 on Friday. CLDX is so predictable. erehdogmai 10/31/17 09:57:40 AM
#1475   will need some new technology to get going again biotech2 10/26/17 11:27:41 AM
#1474   nice. $$$ harry crumb 10/25/17 07:20:58 PM
#1473   Yeah I played it a few years ago erehdogmai 10/25/17 10:55:29 AM
#1472   yes agree but its an oppertunity to add harry crumb 10/25/17 10:38:32 AM
#1471   Waaaay oversold. Looks like dumping or stoplosses.. erehdogmai 10/25/17 09:44:16 AM
#1470   agree, i see it gaining momo in december. $$$$ harry crumb 10/25/17 07:21:08 AM
#1469   CLDX move will take place in 2018 if fwb 10/24/17 10:30:16 AM
#1468   Good question. Will CLDX ever get back above 2014shelby 10/23/17 08:11:44 PM
#1467   How much patience Harry? I have about Keithz 10/23/17 08:01:44 PM
#1466   put another 30k in this today. should be harry crumb 10/23/17 05:32:47 PM
#1465   Like catching a falling knife here. I'm a erehdogmai 10/20/17 10:34:01 AM
#1464   I bought back in early this week for noretreat 10/04/17 04:30:18 PM
#1463   And? Is CLDX gonna come out with some 2014shelby 10/04/17 10:22:24 AM
#1462   Agree. In addition on the biggest up days trebeg 10/04/17 10:21:54 AM
#1461   insiders! harry crumb 10/04/17 09:15:04 AM
#1460   well yeah its better than 3! harry crumb 10/02/17 02:23:20 PM
#1459   Harry...I'd take that and be very happy. CLDX$$$$ trebeg 09/26/17 11:27:03 PM
#1458   A lot of buying leading up to the trebeg 09/26/17 11:24:03 PM
#1457   100% agree! i do believe this crawls to harry crumb 09/26/17 07:55:08 PM
#1456   What happen last week was Insurance Buying. Today fwb 09/26/17 03:03:03 PM